BLK$969.60

BLK demonstrates a mixed but generally positive financial trajectory. Revenue growth has shown strong acceleration in the most recent years, recovering from a deceleration in FY2022 and FY2023. However, this top-line growth has not consistently translated to bottom-line expansion, with Net Income growth becoming negative in FY2025. Gross and operating margins, while initially strong, have seen some compression over the period, indicating potential challenges in cost management relative to revenue increases. Other Non-Operating Income has been volatile, with a significant positive spike in FY2021 and FY2023, and a negative swing in FY2025, suggesting some one-off factors influencing pretax income. Assuming BLK is an asset manager, the fee-based revenue seems robust. The recent decline in Net Income and EPS, coupled with margin compression and increased shares outstanding, are concerning trends that warrant close monitoring despite overall revenue strength.

BLK exhibits a solid balance sheet, characteristic of a financial services firm. Total Assets have grown consistently from $152,648M in FY2021 to $169,998M in FY2025, supported by increasing Long-Term Investments and Goodwill. While Total Liabilities have also grown from $113,755M to $108,456M over the same period, this is common for financial institutions and remains well-supported by the asset base. Shareholders' Equity has seen healthy expansion, rising from $38,893M to $58,751M, driven by Retained Earnings. Net Cash (Debt) is negative, as expected, increasing from -$7,441M to -$16,296M, reflecting the financing structure of a financial entity. Liquidity remains robust with sufficient Cash & Equivalents. Overall, the balance sheet demonstrates stability and growth consistent with a well-managed financial company.

BlackRock, as an asset manager, exhibits a cash flow profile typical of a financial company, where traditional FCF metrics are less indicative of operational health. Operating cash flow has shown significant volatility, declining from $4,944 million in FY2021 to $3,927 million in FY2025, with a notable dip in FY2023. Capital expenditures are relatively stable and low, suggesting controlled asset investments. Free cash flow has largely mirrored operating cash flow trends, showing a similar decline and volatility. The company consistently repurchases common stock and pays substantial dividends, indicating a commitment to returning capital to shareholders. However, the increasing reliance on long-term debt issuance in FY2024 and significant payments for business acquisitions, especially in FY2024 and FY2025, warrant close monitoring.

BLK, an asset manager, is assessed based on financial company guidelines. Liquidity ratios like current and quick ratios are not directly applicable. Leverage, represented by Debt/Equity, has seen a slight increase from 0.24 to 0.26 in the most recent period, remaining within acceptable limits for a financial institution. Efficiency, measured by Asset Turnover, shows a slight upward trend from 0.12 to 0.16, which is structurally low but consistent with the financial sector. Profitability and Returns are generally solid, with ROE around 10.99% and ROA at 3.56% in the latest period, indicating healthy returns. Capital stability appears sound, with a growing equity base implicit in the consistent performance. Overall, BLK demonstrates good financial health with robust profitability and manageable leverage.

BLK demonstrates a strong recovery and growth trajectory following a period of contraction. Historically, revenue experienced declines in FY 2022 and FY 2023, while EPS dipped in FY 2022. However, the forecast years from FY 2024 to FY 2027 show consistent and robust revenue growth, ranging from 10.56% to 18.67%. EPS growth also mirrors this recovery, with significant increases projected, notably in FY 2026 at 55.65%, although FY 2025 sees a temporary dip. The forward P/E ratios for FY 2026 (17.67x) and FY 2027 (15.55x) appear reasonable given the strong projected growth. Analyst sentiment is positive with a "Strong Buy" consensus rating and a healthy average price target of $1260. While the number of 'Strong Buy' recommendations slightly decreased from October '25 to March '26, the overall sentiment remains optimistic with strong coverage.